PAVM PAVmed Inc.

$4.35 -12.12%

Healthcare · Surgical & Medical Instruments & Apparatus

PAVmed Inc. (PAVM) is a healthcare company in the Surgical & Medical Instruments & Apparatus industry, with a market capitalization of $32 million. Shares last traded at $4.35, 84.6% below their 52-week high. Over the past year the stock is up 584.8%. Net profit margin is -5315.5%, below the peer median of -7.6%. Revenue declined 97.6% year over year.

Market Cap

$32M

Shares Out

7.3M

EPS (TTM)

$5.70

P/E Ratio

0.76

P/S Ratio

445.58

P/B Ratio

0.80

Dividend / Share

—

Dividend Yield

—

52-Week High

$28.27

52-Week Low

$0.21

Volume

4,490

Avg Vol (3m)

430.683

Performance

-13.00%

-30.95%

-57.77%

+1205.91%

YTD

-28.22%

+584.82%

Chart

Full chart →

Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.

Technicals

RSI (14)

18.15

SMA (50)

$7.23

SMA (200)

$4.99

Price vs SMA50

-39.86%

Price vs SMA200

-12.76%

ATR (14)

$0.32

Financials

Revenue

$0M

Net Income

$-4M

Gross Margin

-119.7%

Operating Margin

-30712.7%

Net Margin

-5315.5%

Return on Equity

-9.5%

Return on Assets

-8.3%

Current Ratio

2.02

Debt / Equity

0.52

Revenue Growth (YoY)

-97.6%

Latest reported annual period ending 2025-12-31 · SEC EDGAR/XBRL.

Recent earnings

Period	EPS (diluted)	Reported
Q1 2026	$-4.42	2026-05-14
FY 2025	$-5.63	2026-03-27
Q3 2025	$-0.11	2025-11-12
Q2 2025	$0.13	2025-08-14
Q1 2026	$10.10	2026-05-14
FY 2025	$14.90	2026-03-27

Full earnings history →

Surgical & Medical Instruments & Apparatus peers

PAVM vs 14 industry peers (Surgical & Medical Instruments & Apparatus), by market cap.

P/S vs peers

445.58 / 2.52 med

+17593% premium

Net margin vs peers

-5315.5% / -7.6% med

below median

1–14 of 14


SYK	Stryker Corporation	$118.1B	36.38	4.70	12.9%	+2.28%
MMM	3M	$83.9B	25.82	3.36	13.0%	+1.10%
BSX	Boston Scientific	$67.3B	23.27	3.35	14.4%	+0.64%
BDX	Becton Dickinson	$39.7B	23.64	1.82	7.7%	+1.62%
MDLN	Medline Inc.	$29.4B	—	—	—	-1.47%
DXCM	DexCom	$28.0B	33.43	6.00	17.9%	+1.69%
RMD	ResMed	$27.4B	19.53	5.32	27.2%	+1.24%
WST	West Pharmaceutical Services	$23.2B	46.92	7.54	16.1%	+1.35%
SOLV	Solventum	$13.1B	—	—	—	+1.21%
PEN	Penumbra Inc	$12.5B	70.18	8.88	12.7%	+0.28%
GMED	Globus Medical Inc	$10.8B	19.99	3.66	18.3%	+5.00%
BAX	Baxter International	$10.3B	-10.74	0.91	-8.5%	+2.58%
PODD	Insulet Corporation	$10.1B	40.84	3.73	9.1%	+1.51%
GKOS	Glaukos Corp	$7.7B	-40.92	15.13	-37.0%	+2.53%

Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.